Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7788]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer
New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer
PLX3397 may provide a new treatment option for patients with recurrent pigmented villonodular synovitis
PLX3397 may provide a new treatment option for patients with recurrent pigmented villonodular synovitis
NICE rejects use of abiraterone for advanced prostate cancer before chemo
NICE rejects use of abiraterone for advanced prostate cancer before chemo
IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival
IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival
IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models
IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models
IMPAKT: Adoption of multi-gene assays in hormone receptor-positive, HER2-negative breast cancer
IMPAKT: Adoption of multi-gene assays in hormone receptor-positive, HER2-negative breast cancer
IMPAKT: Enzalutamide with or without an aromatase inhibitor for advanced breast cancer
IMPAKT: Enzalutamide with or without an aromatase inhibitor for advanced breast cancer
IMPAKT: Combination of mTOR and AKT inhibitors in patients with advanced breast cancer
IMPAKT: Combination of mTOR and AKT inhibitors in patients with advanced breast cancer
Current guidelines underestimate US cervical cancer incidence and older women’s risk of developing the disease
Current guidelines underestimate US cervical cancer incidence and older women’s risk of developing the disease
Promising combination treatment demonstrates safety and tolerability in patients with most aggressive form of skin cancer
Promising combination treatment demonstrates safety and tolerability in patients with most aggressive form of skin...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation